Diabetes surge hits every nation

One in ten of the world's population will have diabetes by 2035 according to the International Diabetes Federation (IDF). The latest edition IDF Diabetes Atlas, published today on World Diabetes Day, estimates that people living with diabetes will surge from 382 million to 59 2 million people by 2035, many in low and middle income countries and the majority under 60. This surge will form the backdrop of the World Diabetes Congress (#WDC2013) in Melbourne, Australia this December.

In some Pacific Island nations there has been an alarming surge in diabetes prevalence. One adult in three has the disease on the Pacific Island of Tokelau, providing a microcosm of how diabetes could play out in more populous nations within the coming decades.Sub-Saharan Africa will see a doubling in the number of people with diabetes by 2035, the largest surge of any region in the world.

Previous estimates from the IDF Diabetes Atlas in 2012 put the number of people with diabetes at 371 million and number of deaths for 2012 at 4.8 million. The new figures show that the upward trend will continue. By the end of 2013, 5.1 million people will have died from diabetes related complications. With 175 million undiagnosed cases many people are progressing towards complications unawares.

Chinawith 98 million, India with 65 million and the USA with 24 million have the highest numbers of people with diabetes. Regionally the Western Pacific, which includes countries such as Australia, China and Japan, has 138 million people with diabetes, the highest number of people with the disease in the world.

"Diabetes is a disease of development. The misconception that diabetes is 'a disease of the wealthy' is still held, to the detriment of desperately needed funding to combat the pandemic" said Sir Michael Hirst, President of IDF speaking at the International Diabetes Leadership Forum in Istanbul, Turkey. "On World Diabetes Day, we must continue to increase awareness of the importance of a healthy diet and physical activity. Crucially, environments must be created that lay the foundations for healthy living."

Other findings from the 6th edition Diabetes Atlas include:

  • 548 billion USD were spent on diabetes in 2013
  • North America spends the most healthcare dollars on diabetes
  • In South East Asia almost half of all people with diabetes are undiagnosed
  • The Western Pacific has the largest number of people with diabetes in the world
  • In Africa, three quarters of diabetes deaths are in people under 60 years old
  • In the Middle East and North Africa, one in ten people have diabetes
  • In South and Central America, there will be a 60% increase in the number of people with diabetes within a generation

The release of these figures underlines the urgency around IDF's commitment to see diabetes and other Non-communicable Diseases (NCDs) included in an overarching health target in the post-2015 development framework. This will ensure a whole-of-society approach to prevention, treatment, care and support for diabetes and NCDs.

It is hoped that campaigns such as today's World Diabetes Day will continue to raise the voice of people with diabetes and to encourage all stakeholders to move from advocacy to action on a global scale.

About World Diabetes Day
World Diabetes Day (WDD) is celebrated every year on November 14. The World Diabetes Day campaign is led by the International Diabetes Federation (IDF) and its member associations. It engages millions of people worldwide in diabetes advocacy and awareness. World Diabetes Day was created in 1991 by the International Diabetes Federation and the World Health Organizati on in response to growing concerns about the escalating health threat that diabetes now poses. World Diabetes Day became an official United Nations Day in 2007 with the passage of United Nation Resolution 61/225. The campaign draws attention to issues of paramount importance to the diabetes world and keeps diabetes firmly in the public spotlight. This year sees the fourth of a five-year campaign that will address the growing need for diabetes education and prevention programmes.

About the International Diabetes Federation (IDF)
The International Diabetes Federation (IDF) is an umbrella organisation of over 200 national diabetes associations in over 160 countries. It represents the interests of the growing number of people with diabetes and those at risk. The Federation has been leading the global diabetes community since 1950. IDF's mission is to promote diabetes care, prevention and a cure worldwide.

Most Popular Now

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...

500,000 missed out on blood pressure lowering drug…

Nearly half a million people missed out on starting medication to lower their blood pressure during the COVID-19 pandemic, according to research supported by the British ...

Roche announces the European Commission approval o…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission (EC) has approved Xofluza® (baloxavir marboxil) in children aged one year and above for the trea...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Discovery of anti-cancer chemistry makes skullcap …

The evolutionary secrets that enable the medicinal herb known as barbed skullcap to produce cancer fighting compounds have been unlocked by a collaboration of UK and Chin...

A soybean protein blocks LDL cholesterol productio…

A protein in soybeans blocks the production of a liver enzyme involved in the metabolism of triglycerides and low-density lipoprotein, scientists found in a recent study...